MCKESSON CORP
Close on Oct 19, 2026
- Market cap
- $120.44B
- P/E (TTM)
- 27.1
- Dividend yield
- 0.31%
About Mckesson
Wholesale-Drugs, Proprietaries & Druggists' Sundries, SIC 5122
McKesson Corporation is an enterprise involved in healthcare distribution and support services. Operating across distinct operating segments including North American Pharmaceutical, Medical-Surgical Solutions, Oncology and Multispecialty, and Prescription Technology Solutions, the company supplies pharmaceuticals, medical-surgical products, and specialized technology infrastructure. Its operations serve broad healthcare customers through established provider networks, distribution channels, and integrated care solutions across multiple clinical disciplines.
The text indicates business presence across North America and several international jurisdictions, citing operational activities and tax affiliations in Canada, the United Kingdom, Germany, and Luxembourg. The report details physical property, equipment, and network assets across domestic and overseas sites, alongside historical retail operations in Canada and Norway. The provided filing text does not disclose the city or state of the company's headquarters.
Summary of the business section of Mckesson's latest annual report, written by StockData.
Company profile
Company
- Legal name
- MCKESSON CORP
- Founded
- 1833
- Headquarters
- Irving, TX
- Address
- 6555 State Highway 161 75039
- Phone
- (972) 446-4800
- Website
- www.mckesson.com
- Employees
- 43,000, Mar 31, 2026
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Incorporated in
- Delaware
- Fiscal year ends
- March 31
- Auditor
- Deloitte & Touche LLP, Dallas, Texas
Stock & identifiers
- Ticker
- MCK
- Exchange
- NYSE
- Shares outstanding
- 117M, Jul 31, 2026
- Public float
- $95.30B, Sep 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Jan 5, 1998
- SEC CIK
- 927653
- CUSIP
- 58155Q103
- ISIN
- US58155Q1031
- LEI
- 549300WZWOM80UCFSF54
- EIN
- 94-3207296
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Brian S. Tyler | Chief Executive Officer, Director | 6,135 |
| Napoleon B. Rutledge JR | SVP, Controller & CAO | 521 |
| Ramesh (NMN) Srinivasan | EVP and Chief Strategy Officer | 11,959 |
| Thomas L. Rodgers | EVP, Chief Strategy & BDO | 2,268 |
| LeAnn B. Smith | EVP & Chief HR Officer | 4,798 |
| Kenny K. Cheung | EVP & CFO | – |
| Francisco Fraga | EVP, CIO and CTO | 6,264 |
| Britt J. Vitalone | EVP & CFO | 22,506 |
| Michele Lau | EVP and Chief Legal Officer | 3,386 |
| Bradley E. Lerman | Director | 0 |
| Deborah Dunsire | Director | – |
| Julie L. Gerberding | Director | – |
| Lynne M. Doughtie | Director | – |
| James H. Hinton | Director | – |
| Webster Roy Dunbar | Director | – |
| Kevin M. Ozan | Director | 15 |
| Dominic J. Caruso | Director | 927 |
| Kathleen Wilson-Thompson | Director | 578 |
| Maria Martinez | Director | 578 |
| Donald R. Knauss | Director | 2,069 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2026 Brian S. Tyler | $24.21M | $48.93M | $5.49M | $456 | $137 |
| FY2025 Brian S. Tyler | $20.16M | $39.17M | $4.96M | $353 | $134 |
| FY2024 Brian S. Tyler | $19.00M | $51.71M | $5.20M | $281 | $133 |
| FY2023 Brian S. Tyler | $20.22M | $38.81M | $4.90M | $185 | $115 |
| FY2022 Brian S. Tyler | $18.15M | $65.28M | $4.51M | $158 | $119 |
| FY2021 Brian S. Tyler | $14.84M | $33.05M | $4.27M | $146 | $134 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of March 31, 2026, we had more than 43,000 employees worldwide, which includes 1,400 part-time employees.”
Corporate history
Events identified from SEC filings